Adults 40–75 who have COPD and experienced a flare-up in the past year may qualify for a study evaluating an investigational treatment.
Chronic Obstructive Pulmonary Disease (COPD)
Age Range:
40 to 75
Gender:
Male and Female
Location:
West Chester, Pennsylvania
About the Study
COPD flare-ups can be stressful and may make breathing even harder. Many people still experience flare-ups even while using their daily inhalers.
This research study is looking at an investigational injectable medication. The purpose is to learn whether targeting a specific type of inflammation found in some people with COPD may help reduce future flare-ups.
Participants will continue using their regular COPD inhalers throughout the study.
Qualifications
You may be able to join if you:
- Are 40 to 75 years old
- Have COPD diagnosed at least one year ago
- Had 1 COPD flare-up in the past year that required steroid treatment
- Are a current or former smoker with 10+ pack-years
- Are using dual or triple inhaler therapy (such as ICS/LABA, LABA/LAMA, or ICS/LABA/LAMA)
- Have Type 2 inflammation, shown by higher eosinophils (can be tested during screening)
FEATURED STUDIES
General Anxiety Disorder
Individuals with generalized anxiety disorder (GAD) who experience ongoing worry, stress, or difficulty managing anxiety symptoms may qualify for a
COPD
Individuals with chronic obstructive pulmonary disease (COPD) who continue to experience symptoms or flare-ups despite treatment may qualify for a
MDD Study
Adults 18 to 65 years of age with Major Depressive Disorder (MDD) may qualify for a clinical research study evaluating
Chronic Obstructive Pulmonary Disease (COPD)
Adults 40–75 who have COPD and experienced a flare-up in the past year may qualify for a study evaluating an
Post-Traumatic Stress Disorder (PTSD)
Adults 18 and older living with post-traumatic stress disorder (PTSD) may qualify for a clinical research study evaluating an investigational
Bronchiectasis
Individuals with bronchiectasis who experience frequent flare-ups or ongoing respiratory symptoms may qualify for a research study evaluating a home